Remove FDA Remove Licensing Remove World Health
article thumbnail

The Global Challenge of Unhealthy Diets: Front-of-Package Labeling for America

Bill of Health

Food and Drug Administration (FDA) is expected to propose new rulemaking on front-of-package labeling in 2024. The World Health Organization (WHO) has recommended FOP labeling as a cost-effective intervention to improve population-level dietary habits. Since 2009, the U.S. No standardized system exists but the U.S.

article thumbnail

Where telemedicine is headed now that the PHE has ended

Healthcare IT News - Telehealth

This also happens to coincide with the World Health Organization declaring an end to the COVID-19 global health emergency. What can be expected in healthcare and health IT now that the PHE has ended, and what does this mean for the future of telehealth? The fact is nothing that dramatic happened on the day the PHE ended.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary for March and April 2024

SQA

The adoption of these mechanisms is recommended and encouraged by the World Health Organization (WHO) so that the population has faster access to health services and technologies. CDSCO is looking to adopt the use of this guidance for premarket license applications and post-approval change applications. Kappin Ltd.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. PCPC looks forward to working with the FDA and key stakeholders to implement this important legislation.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

Since health authorities have not yet published guidelines for a comprehensive control strategy specific to microbiological topics for ATMPs, it is up to the individual ATMP sponsor or license holder to apply these compendial references properly. United States Food and Drug Administration (FDA) – Regulations and guidance.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

The US FDA has already recognized the ability of 16 EU Member States to conduct GMP inspections of manufacturers of veterinary medicinal products. At the same time, the EU has recognized the US FDA as an equivalent authority to carry out these inspections.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

At the same time, the EU has recognized the US FDA as an equivalent authority to carry out these inspections. FDA ensures that broad-spectrum sunscreens protect against both Ultraviolet A (UVA) and Ultraviolet B (UVB) radiation and are safe and effective. Understanding CDERs Risk-Based Site Selection Model.

FDA 40